A DESCRIPTION OF THE DRUG INFORMATION CENTRE IN INDIA INCLUDING ITS FUNCTIONS AND CHALLENGES

Abstract

The provision of drug information involves the dissemination of data regarding the pharmaceuticals utilised within the health-care system. In addition, it encompasses the administration of appropriate doses, the monitoring and management of adverse drug reactions (ADRs) and side effects, the study of pharmacokinetic characteristics, the education of healthcare personnel, the handling of drug shortages, the identification of alternative treatments, and the creation of alternative protocols for limited use. The objective of medication information is to provide authentic, accurate, relevant, unbiased drug information to patients, nursing staff, practicing physicians, chemists, and other healthcare professionals. Drug information frequently addresses inquiries from patients and healthcare providers. The drug information centre regularly gets inquiries from hospital personnel and patients, and provides responses regarding adverse drug reactions (ADRs), drug interactions, pharmacokinetic properties of medications, and information on newly available drugs in the market. Drug information services contribute to enhancing patient safety, reducing drug-related complications for the patient, and promoting the judicious utilisation of medications by both healthcare providers and patients. Drug information services offer clear and precise information with the assistance of a highly skilled and licenced clinical chemist. The majority of wealthy nations are effectively utilising this service. These centres in highly developed nations promptly deliver precise and current drug information to healthcare practitioners. Nevertheless, it is imperative for emerging nations such as India to prioritise the enhancement of their service sector. The material contained in this paper not only provides insights into drug information services, but also highlights future considerations that must be addressed.